For the applications I see clients wanting to buy, no. Both the maturity and cost-saving potential of GenAI are greatly over-hyped.

From a non-tech business perspective, I expect the interest in GenAI to decline by years end. It's just not materialising the value stakeholders are expecting to see for the exorbitant investment.